Danish pharmaceutical company Novo Nordisk is preparing to introduce its innovative weight management drug, Ozempic ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ ...

U.S. President Donald Trump on Thursday unveiled a 100% tariff on imports of branded drugs from October 1, unless their ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

The pharmaceutical company that has become central to the Danish economy is readying to cut some 5,000 jobs in its home ...

Medicare Part D beneficiaries experienced a large increase in out-of-pocket spending for GLP-1s in 2025, according to ...

Gates Foundation and Novo Nordisk Novo Nordisk Foundation have extended the Acetate Consortium initiative with a $25.6M ...

( NewsNation) — New research has revealed that oral semaglutide can help with significant weight loss, with one in three ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.